Lifestyle Physical Activity Intervention for Persons Newly Diagnosed With Multiple Sclerosis - Trial NCT06355804
Access comprehensive clinical trial information for NCT06355804 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Illinois at Chicago and is currently Recruiting. The study focuses on Multiple Sclerosis. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Illinois at Chicago
Timeline & Enrollment
N/A
Apr 29, 2024
Apr 22, 2025
Primary Outcome
Physical Activity Behavior,Physical Activity Behavior,Physical Activity Level (Light physical activity),Physical Activity Level (Moderate-to-vigorous physical activity),Physical Activity Level (Daily step count)
Summary
The overall objective of the current study is to determine the efficacy of a 16-week remotely
 delivered lifestyle behavioral intervention compared with a control condition (i.e., waitlist
 control) in persons newly diagnosed with MS (disease duration ≤ 2 years).
 
 Specific Aim 1: To evaluate the changes in self-report and device-measured physical activity
 after the 16-week remotely delivered physical activity behavior change intervention compared
 with a control condition (i.e., waitlist control) in persons who have diagnosed with MS
 within the past two years. The investigators hypothesize that the 16-week behavior change
 intervention will yield greater improvements in physical activity levels than the control
 condition immediately after the intervention.
 
 Specific Aim 2: To investigate the efficacy of the 16-week, remotely delivered physical
 activity behavior change intervention compared with the control condition for improvements in
 fatigue, depression, anxiety, and QoL in persons newly diagnosed with MS. The investigators
 hypothesize that there will be beneficial effects on the symptoms and QoL outcomes
 immediately after the physical activity intervention compared with minimal changes in the
 control condition.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06355804
Non-Device Trial